{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:05:31Z","timestamp":1771257931265,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,16]]},"DOI":"10.7759\/cureus.103716","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T15:10:38Z","timestamp":1771254638000},"source":"Crossref","is-referenced-by-count":0,"title":["Salvage Resection Following Reassessment of Resectability in Advanced Hepatocellular Carcinoma"],"prefix":"10.7759","author":[{"given":"Dimitrios K","family":"Vlachos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michail","family":"Konstantinidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dionysios","family":"Prevezanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Machairas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios C","family":"Sotiropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel RL","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024, 74:12-49. 10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02075-w","article-title":"Hepatocellular carcinoma: signaling pathways and therapeutic advances","volume":"10","author":"Zheng J","year":"2025","unstructured":"Zheng J, Wang S, Xia L, et al.. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther. 2025, 10:35. 10.1038\/s41392-024-02075-w","journal-title":"Signal Transduct Target Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig M","year":"2022","unstructured":"Reig M, Forner A, Rimola J, et al.. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022, 76:681-93. 10.1016\/j.jhep.2021.11.018","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-01807-4","article-title":"Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis","volume":"21","author":"Chen YS","year":"2021","unstructured":"Chen YS, Hsieh PM, Lin HY, et al.. Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis. BMC Gastroenterol. 2021, 21:220. 10.1186\/s12876-021-01807-4","journal-title":"BMC Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2646-2","article-title":"Survival benefit of surgical treatment for hepatocellular carcinoma with inferior vena cava\/right atrium tumor thrombus: results of a retrospective cohort study","volume":"20","author":"Wang Y","year":"2013","unstructured":"Wang Y, Yuan L, Ge RL, Sun Y, Wei G. Survival benefit of surgical treatment for hepatocellular carcinoma with inferior vena cava\/right atrium tumor thrombus: results of a retrospective cohort study. Ann Surg Oncol. 2013, 20:914-22. 10.1245\/s10434-012-2646-2","journal-title":"Ann Surg Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.865","article-title":"Surgery versus external beam radiotherapy for hepatocellular carcinoma involving the inferior vena cava or right atrium: a systematic review and meta-analysis","volume":"28","author":"Lee HA","year":"2021","unstructured":"Lee HA, Park S, Seo YS, Yoon WS, Shin IS, Rim CH. Surgery versus external beam radiotherapy for hepatocellular carcinoma involving the inferior vena cava or right atrium: a systematic review and meta-analysis. J Hepatobiliary Pancreat Sci. 2021, 28:1031-46. 10.1002\/jhbp.865","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-11-259","article-title":"Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium","volume":"11","author":"Wakayama K","year":"2013","unstructured":"Wakayama K, Kamiyama T, Yokoo H, et al.. Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium. World J Surg Oncol. 2013, 11:259. 10.1186\/1477-7819-11-259","journal-title":"World J Surg Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-017-1619-2","article-title":"Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium","volume":"48","author":"Sakamoto K","year":"2018","unstructured":"Sakamoto K, Nagano H. Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium. Surg Today. 2018, 48:819-24. 10.1007\/s00595-017-1619-2","journal-title":"Surg Today"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn.2019.10.07","article-title":"A new classification for hepatocellular carcinoma with hepatic vein tumor thrombus","volume":"9","author":"Chen ZH","year":"2020","unstructured":"Chen ZH, Wang K, Zhang XP, et al.. A new classification for hepatocellular carcinoma with hepatic vein tumor thrombus. Hepatobiliary Surg Nutr. 2020, 9:717-28. 10.21037\/hbsn.2019.10.07","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain V","year":"2017","unstructured":"Vilgrain V, Pereira H, Assenat E, et al.. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. Lancet Oncol. 2017, 18:1624-36. 10.1016\/S1470-2045(17)30683-6","journal-title":"Lancet Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/465721-salvage-resection-following-reassessment-of-resectability-in-advanced-hepatocellular-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T15:10:39Z","timestamp":1771254639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/465721-salvage-resection-following-reassessment-of-resectability-in-advanced-hepatocellular-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.103716","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,16]]}}}